Daily Morning Note – 11 November 2020

PHILLIP SUMMARY

Wall Street pulled back from the celebration that followed good news on a potential Covid-19 vaccine, ending Tuesday’s session mixed. The benchmark Dow Jones Industrial Average finished the day with a 0.9 per cent gain at 29,420.92, while the broader S&P 500 dipped 0.1 per cent to 3,545.53. But the tech-heavy Nasdaq lost 1.4 per cent to close at 11,553.86. Optimism about Monday’s announcement from Pfizer and BioNTech that their vaccine was 90 per cent effective was tempered by the realisation the economic gains likely will not be felt until late next year since it will take months for any vaccine to be widely distributed.

On the other side, European shares held near eight-month highs on Tuesday, riding a wave of optimism about a Covid-19 vaccine breakthrough, although concerns about the pandemic’s economic damage capped gains. The pan-European Stoxx 600, which rallied 4 per cent on Monday after positive news from US drugmaker Pfizer about its Covid-19 vaccine candidate, rose 0.9 per cent. The European Commission said it will approve on Wednesday a contract for the supply of Pfizer and its partner BioNTech’s potential coronavirus vaccine.

BREAKING NEWS

Quarz Capital and Black Crane Capital, in a letter sent on Tuesday and seen by The Business Times, have made a requisition to the board of Sabana Shari’ah Compliant Industrial Real Estate Investment Trust’s (Sabana Reit) manager to convene an extraordinary general meeting (EGM).

Bukit Sembawang Estates reported a net profit of S$73.7 million for the first half of its financial year ending in September, up 11 per cent from S$66.6 million the year before. The group’s earnings per share were lifted to 28.45 cents, up from 25.73 cents last year.

First Reit distribution per unit (DPU) of First Reit fell 53 per cent to 1.01 Singapore cent for the third fiscal quarter ended September, compared to 2.15 cents a year ago. This brings the Reit’s DPU for the first nine months of the year to 3.31 cents, some 48.7 per cent lower than 6.45 cents in the year-ago period.

Keppel Land China, a subsidiary of Keppel Land, is divesting its 100 per cent stake in Chengdu Hilltop Development Co Ltd for an aggregate amount of 1.26 billion yuan (S$250.4 million). The transaction, entered into by Keppel Land China’s subsidiary Hillwest Pte Ltd, is expected to earn the company a divestment gain of approximately S$43 million.

Chinese e-commerce giant Alibaba Group Holding kicked off its annual Singles’ Day mega-shopping event on Wednesday, looking to cash in on consumers itching for discounts as the economy rebounds from the COVID-19 crisis. This year’s online shopping extravaganza also comes a week after Alibaba lost almost US$76 billion of its market value, following China’s suspension of the US$37 billion listing of Ant Group, the financial technology firm Alibaba owns a third of.

Oil ended nearly 3 per cent higher on Tuesday as hopes that a Covid-19 vaccine is on the horizon outweighed worries about a drop in fuel demand from new lockdowns to contain the virus. Brent crude futures settled up US$1.21, or 2.9 per cent, at US$43.61 per barrel. US West Texas Intermediate (WTI) crude futures gained US$1.07, or 2.7 per cent, to US$41.36.

News of a breakthrough in the race to find a Covid-19 vaccine sparked one of the heaviest trading days since the height of the pandemic crisis, according to early data analysed by Reuters, with nearly US$2 trillion changing hands on Monday. Traders stampeded to the riskier plays in equities, foreign exchange and bond markets after Pfizer Inc released positive data on its vaccine trial, while rotating out of safe havens such as technology stocks, Japanese yen and top-rated bonds.

Boeing said on Tuesday it was hit with another 12 cancelled orders for the 737 MAX, as the flagship aircraft is close to returning to the skies after being grounded since March 2019 following two deadly crashes.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR

RESEARCH VIDEOS

Webinar Of The Week

Market Outlook: (PSR) StarHub, Banks & REIT Results, Banking Monthly, Credit Commentary, SG Weekly & more

Date: 09 November 2020

For more on Market Outlook

Updates summarised in 3 minutes

Phillip Research in 3 minutes: #26 – iX Biopharma Ltd; Initiation

For more videos on Phillip in 3 Mins

Read the research report(s), available through the link(s) above, for complete information including important disclosures Important Information





Disclaimer
The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

 

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com